Summary
Overview
Work History
Education
Skills
Timeline
Generic

Reagan Tully

Scottsdale,AZ

Summary

Strategic enterprise leader skilled in scaling healthcare and life sciences businesses, enhancing P&L performance, and driving market expansion. Led profitable growth initiatives, built high-performing teams, and executed complex strategies, including capital raises and global expansion. Expertise in stakeholder relations, supply chain management, and strategic planning, translating executive directives into actionable initiatives.

Overview

27
27
years of professional experience

Work History

Vice President, Commercial – Fisher Healthcare

THERMO FISHER SCIENTIFIC
Pittsburgh, PA
2025.01 - Current
  • Lead the commercial organization for a $1.8B healthcare distribution and diagnostics business, overseeing sales, strategic accounts, government, capital solutions, and commercial operations across a 3M+ product portfolio.
  • Selected by executive leadership to serve as Interim President (2025) with full P&L ownership.
  • Delivered 22% YoY EBITA growth; reduced OpEx from 6% to 4.5% and increased operating cash flow by $30M YoY
  • Rebuilt commercial model (key accounts, capital center of excellence, virtual sales) to enhance scalability and execution
  • Deployed IDN strategy and pricing architecture, strengthening partnerships with large health systems
  • Led enterprise Kaizen initiatives improving margin realization and operational efficiency
  • Navigated external headwinds, achieving $10M in net favorability
  • Upgraded leadership team and reduced voluntary attrition to

Chief Commercial and Business Officer

BIOSKRYB GENOMICS
Durham, NC
2022.01 - 2024.01
  • Scaled global genomics business across commercial operations, corporate development, investor strategy, enhancing market presence and stakeholder engagement.
  • Grew revenue 11x ($1.2M to $14M) while maintaining disciplined cost structure
  • Increased company valuation from $90M to $300M
  • Closed >$1B in long-term strategic partnerships (10+ year agreements)
  • Led $14M debt financing and initiated $50M Series A raise
  • Expanded operations from North America to EMEA and APAC, establishing global commercial infrastructure to support international growth.
  • Rebuilt go-to-market model, increasing pipeline generation 27x

Chief Marketing Officer

CARIS LIFE SCIENCES
Phoenix, AZ
2020.01 - 2022.01
  • Shared responsibility for multi-billion-dollar precision medicine business performance; led global marketing, product strategy, growth initiatives to optimize market impact.
  • Achieved 40% YoY growth through integrated commercial and partnership strategies, enhancing market presence and revenue.
  • Led brand transformation and national DTC campaign generating ~90M impressions and significant demand growth
  • Drove digital transformation, increasing traffic by 40%, users by 103%, and engagement across channels, significantly boosting online presence.
  • Established strategic partnerships and EMR integrations to expand market access and utilization

Vice President, Office of Customer Focus & Delivery

MCKESSON
Scottsdale, AZ
2018.01 - 2020.01
  • Drove 28% revenue growth and 40% margin expansion through portfolio, pricing, and commercial strategy
  • Achieved 17% OpEx reduction and enhanced profitability through organizational transformation initiatives.
  • Led operations, strategy, and commercial functions across life sciences businesses, overseeing P&L of $500M and 3,000+ employees to drive business growth.
  • Generated $255M in incremental working capital; improved accounts receivable by 94%
  • Monetized data and services, resulting in $10M in incremental revenue through targeted commercial strategies.

Vice President, Strategy & Marketing

MCKESSON
Scottsdale, AZ
2015.01 - 2018.01

Head, US Customer Strategy – Vaccines

GLAXOSMITHKLINE
Philadelphia, PA
2014.01 - 2015.01
  • Led product launch that surpassed plan by 150%
  • Increased operating profit by over 19%, achieving consistent double-digit growth
  • Transformed underperforming regions to achieve #1 national ranking
  • Led commercial strategy, product launches, and integration efforts across a $1.6B P&L.

US Marketing Lead – PROMACTA

GLAXOSMITHKLINE
Philadelphia, PA
2011.01 - 2014.01

US Director of Sales / Regional Director – Oncology

GLAXOSMITHKLINE
Philadelphia, PA
2010.01 - 2011.01

Regional Director, National Operations Manager, and Sales Leadership Roles

SCHERING-PLOUGH CORPORATION
Kenilworth, NJ
1999.01 - 2010.01
  • Oversaw $151M+ revenue portfolio and $55M operating budget, ensuring financial performance and resource allocation aligned with organizational goals.
  • Achieved sustained top-tier commercial performance across multiple brands, contributing to overall market share growth.
  • Transformed lowest-performing region to #1 nationally
  • Led strategic initiatives in oncology, virology, and specialty care, driving growth and operational excellence.

Education

HMX ProGenetics - Cancer Genomics and Precision Medicine

Harvard Medical School
Boston, MA

Executive Education - High-Potential Leaders

The Wharton School, University of Pennsylvania
Philadelphia, PA

Executive Education - Leading High-Performance Teams

University of Texas, McCombs School of Business
Austin, TX

Bachelor of Science - Biomedical Science

Texas A&M University
College Station, TX

Skills

  • Commercial strategy
  • P&L management
  • Sales growth
  • Revenue optimization
  • Strategic partnerships
  • Market analysis
  • Operational efficiency

Timeline

Vice President, Commercial – Fisher Healthcare

THERMO FISHER SCIENTIFIC
2025.01 - Current

Chief Commercial and Business Officer

BIOSKRYB GENOMICS
2022.01 - 2024.01

Chief Marketing Officer

CARIS LIFE SCIENCES
2020.01 - 2022.01

Vice President, Office of Customer Focus & Delivery

MCKESSON
2018.01 - 2020.01

Vice President, Strategy & Marketing

MCKESSON
2015.01 - 2018.01

Head, US Customer Strategy – Vaccines

GLAXOSMITHKLINE
2014.01 - 2015.01

US Marketing Lead – PROMACTA

GLAXOSMITHKLINE
2011.01 - 2014.01

US Director of Sales / Regional Director – Oncology

GLAXOSMITHKLINE
2010.01 - 2011.01

Regional Director, National Operations Manager, and Sales Leadership Roles

SCHERING-PLOUGH CORPORATION
1999.01 - 2010.01

HMX ProGenetics - Cancer Genomics and Precision Medicine

Harvard Medical School

Executive Education - High-Potential Leaders

The Wharton School, University of Pennsylvania

Executive Education - Leading High-Performance Teams

University of Texas, McCombs School of Business

Bachelor of Science - Biomedical Science

Texas A&M University
Reagan Tully